Shandong Weifang pharmaceutical factory co., Ltd. was founded in 1966, the factory covers an area of 16,500 square meters, an area of 14,600 square meters. currently employs 382 people, all kinds of professional and technical personnel of these 112, 11 practising pharmacists. Shandong Weifang pharmaceutical factory co., Ltd. with injection water for injection, powder for injection injections, tablets, capsules and raw materials such as modernization of five major drug production plant, all passed national GMP certification, API workshop also twice in 1998 and 2004, respectively, through United States FDA approval, is the earliest by United States FDA acceptance of captopril raw medicine production enterprises. 
     Shandong Weifang pharmaceutical factory co., Ltd. produce five series of a total of 74 species, perennial 116 specifications of products. the water PIN 100 million of annual production capacity, powder for injection of 52 million, tablets 500 million tablets, capsules 150 million tablets, with 150 tons of raw materials. the main varieties are: the wonder drug for treatment of hypertension and congestive heart failure such as captopril, lisinopril; baogan hugan wonder drug "glycosides Paula capsule", and of azlocillin sodium for injection, injection of mezlocillin sodium and ampicillin sodium and sulbactam sodium for injection, penicillin sodium for injection and other products. 
     more than 40 years, the company has been in service for the purpose of human health, increasing our; backed by the knowledge economy, innovation capacity and gradually increased to scientific management as a guarantee, product quality is top-notch; to deepen the reform to power, gradually matured in a market economy. 
    2004 year in August in the economic development zone, Weifang Hanting 120 acres, has initiated the establishment of cardiovascular drugs and antibiotics to the main cultivars of Shandong-German pharmaceutical co., Ltd. (Shandong Weifang pharmaceutical factory co., Ltd. total equity 100%). 
    2004 year in September, the wholly-owned acquisition of Jinan chemical limited liability company for a long time (long time creating chemical), while chemical still retains its independent management for a long time, self-financed independent legal status. create a major research and development direction of perindopril chemical classes for a long time a new alternative, Losartan and anti-AIDS cancer series pharmaceutical product development and approval, and so on. will be targeted at the international market in the future, cooperation with foreign enterprises, and to provide follow-up and Shandong Weifang pharmaceutical German pharmaceutical development products.